Development of an immunomodulatory biomaterial: Using resolvin D1 to modulate inflammation

Biomaterials

Volumn 53, Issue , 2015, Pages 566-573

  Vasconcelos, Daniela P ^a,b,c   Costa, Madalena ^a   Amaral, Isabel F ^b,c   Barbosa, Mário A ^a,b,c   Águas, Artur P ^a   Barbosa, Judite N ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

Chitosan; Immune response; Immunomodulation; Macrophage; Resolvin

Indexed keywords

CHITOSAN; CYTOLOGY; MACROPHAGES; PATHOLOGY;

AIR POUCH MODELS; IMMUNE RESPONSE; IMMUNO MODULATIONS; INFLAMMATORY CELLS; INFLAMMATORY RESPONSE; PRO-INFLAMMATORY CYTOKINES; REPARATIVE RESPONSE; RESOLVIN;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; CHEMOKINE RECEPTOR CCR7; CHITOSAN; IMMUNOMODULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 16; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; RESOLVIN D1; UNCLASSIFIED DRUG; CYTOKINE; DOCOSAHEXAENOIC ACID; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FREEZE DRYING; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TISSUE REGENERATION; ANIMAL; BIOSYNTHESIS; TISSUE SCAFFOLD;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOCOMPATIBLE MATERIALS; CYTOKINES; DOCOSAHEXAENOIC ACIDS; INFLAMMATION; MICE; TISSUE SCAFFOLDS;

EID: 84927935709     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.120     Document Type: Article

References (35)

1. Gower R.M., Boehler R.M., Azarin S.M., Ricci C.F., Leonard J.N., Shea L.D. Modulation of leukocyte infiltration and phenotype in microporous tissue engineering scaffolds via vector induced IL-10 expression. Biomaterials 2014, 35:2024-2031.
2. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. JInvest Dermatol 2007, 127:514-525.
3. Li Y.S., Dalli J., Chiang N., Baron R.M., Quintana C., Serhan C.N. Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. Immunity 2013, 39:885-898.
4. Freire M.O., Van Dyke T.E. Natural resolution of inflammation. Periodontol 2000 2013, 63:149-164.
5. Widgerow A.D. Cellular resolution of inflammation-catabasis. Wound Repair Regen 2012, 20:2-7.
6. Vasconcelos D.P., Costa Madalena, Amaral I.F., Barbosa M.A., Águas A.P., Barbosa J.N. Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators. Biomaterials 2015, 37:116-123.
7. Abdelmoaty S., Wigerblad G., Bas D.B., Codeluppi S., Fernandez-Zafra T., El-Awady el S., et al. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. PloS One 2013, 8:e75543.
8. Franz S., Allenstein F., Kajahn J., Forstreuter I., Hintze V., Moller S., et al. Artificial extracellular matrices composed of collagen I and high-sulfated hyaluronan promote phenotypic and functional modulation of human pro-inflammatory M1 macrophages. Acta Biomater 2013, 9:5621-5629.
9. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32:6692-6709.
10. Kou P.M., Babensee J.E. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. JBiomed Mater Res A 2011, 96:239-260.
11. Mokarram N., Merchant A., Mukhatyar V., Patel G., Bellamkonda R.V. Effect of modulating macrophage phenotype on peripheral nerve repair. Biomaterials 2012, 33:8793-8801.
12. Brown B.N., Londono R., Tottey S., Zhang L., Kukla K.A., Wolf M.T., et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater 2012, 8:978-987.
13. Vachoud L., Zydowicz N., Domard A. Formation and characterisation of a physical chitin gel. Carbohydr Res 1997, 302:169-177.
14. Barbosa J.N., Amaral I.F., Aguas A.P., Barbosa M.A. Evaluation of the effect of the degree of acetylation on the inflammatory response to 3D porous chitosan scaffolds. JBiomed Mater Res A 2010, 93:20-28.
15. Vasconcelos D.P., Fonseca A.C., Costa M., Amaral I.F., Barbosa M.A., Aguas A.P., et al. Macrophage polarization following chitosan implantation. Biomaterials 2013, 34:9952-9959.
16. Sedwick A.D., Sin Y.M., Edwards J.C., Willoughby D.A. Increased inflammatory reactivity in newly formed lining tissue. JPathol 1983, 141:483-495.
17. Castro A.G., Esaguy N., Macedo P.M., Aguas A.P., Silva M.T. Live but not heat-killed mycobacteria cause rapid chemotaxis of large numbers of eosinophils invivo and are ingested by the attracted granulocytes. Infect Immun 1991, 59:3009-3014.
18. Brown B.N., Badylak S.F. Expanded applications, shifting paradigms and an improved understanding of host-biomaterial interactions. Acta Biomater 2013, 9:4948-4955.
19. Couto D.S., Perez-Breva L., Saraiva P., Cooney C.L. Lessons from innovation in drug-device combination products. Adv Drug Deliv Rev 2012, 64:69-77.
20. Wu P., Grainger D.W. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006, 27:2450-2467.
21. Zilberman M. Active implants and scaffolds for tissue regeneration 2011, Springer-Verlag, Berlin Heidelberg.
22. Lewis A. Drug device combination products: delivery technologies and applications 2010, Woodhead Publishing Limited, Cambridge.
23. Domb A.J., Khan W. Focal controlled drug delivery 2014, Springer.
24. Brown B.N., Ratner B.D., Goodman S.B., Amar S., Badylak S.F. Macrophage polarization: an opportunity for improved outcomes in and regenerative medicine. Biomaterials 2012, 33:3792-3802.
25. Wooley P.H., Morren R., Andary J., Sud S.A., Yang S.Y., Mayton L., et al. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 2002, 23:517-526.
26. Hooper K.A., Nickolas T.L., Yurkow E.J., Kohn J., Laskin D.L. Characterization of the inflammatory response to biomaterials using a rodent air pouch model. JBiomed Mater Res 2000, 50:365-374.
27. Winyard P.G., Willoughby D.A. Methods in molecular biology. Inflammation protocols 2003, Humana Press, New Jersey.
28. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. JExp Med 2000, 192:1197-1204.
29. Hsiao H.M., Sapinoro R.E., Thatcher T.H., Croasdell A., Levy E.P., Fulton R.A., et al. Anovel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PloS One 2013, 8. e58258.
30. Titos E., Rius B., Gonzalez-Periz A., Lopez-Vicario C., Moran-Salvador E., Martinez-Clemente M., et al. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. JImmunol 2011, 187:5408-5418.
31. Di Tommaso C., Como C., Gurny R., Moller M. Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations. Eur J Pharm Sci 2010, 40:38-47.
32. Howard M.D., Lu X.L., Jay M., Dziubla T.D. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Drug Dev Ind Pharm 2012, 38:1270-1279.
33. Maderna P., Godson C. Lipoxins: resolutionary road. Br J Pharmacol 2009, 158:947-959.
34. Mitchell S., Thomas G., Harvey K., Cottell D., Reville K., Berlasconi G., et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils invivo. JAm Soc Nephrol 2002, 13:2497-2507.
35. Hubbell J.A., Thomas S.N., Swartz M.A. Materials engineering for immunomodulation. Nature 2009, 462:449-460.